Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma

We analyzed 149 women (81 with cervical intraepithelial neoplasia and with invasive carcinoma of the cervix and 68--as a control group). The influence of Chlamydia trachomatis (Cht) infection into expression of EGFR, TGF-alpha, Ki 67, HPV 16 and 18 was examined. IS-PCR was used to measure the level of antibodies in the serum. We detected that chlamydial infection may cause cervical hypertrophy in women with and without cervical intraepithelial neoplasia and invasive carcinoma. Infections of both Cht and HPV correlate with high expession of Ki 67 in epithelium. Cht infection also increased the expression of HPV16 in CIN I. These results suggest that Cht infection modifies the activity of viruses. In our research we have confimed that Cht infection increases the expression of EGFR and TGF-alpha. These facts may explain variants other than the HPV-mechanism of cervical carcinogenesis.

Chlamydia trachomatis; Cervical cancer; CIN

[1] Zur Hausen H.: Cervical carcinoma and human papillomav1rus: on the road to preventing a major human cancer". J. Natl. Cancer Inst., 2001, 93 (4), 252.

[2] Aquilar-Lemarroy A., Kirchoff S., Whitaker N. et al.: "Differential sensitivity of human pap仆lomavirus type 16(+) and type 18(+) cervical carcinoma cell to CD-95-mediated apoptosis". Int. J. Cancer, 2001, 93 (6), 823.

[3] Zur Hausen H.: "Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis". J. Natl. Cancer Inst.,2 000, 92 (9), 690.

[4] Howley P. M., Scheffner M., Munger K.: "Oncoproteins encoded by the cancer-associated human papillomavirus target the products of the retinoblastoma and p53 tumor suppressor genes". Cold Spring Symp. Quant. Biol., 1991, 56, 149.

[5] Zur Hausen H.: "Papillomaviruses in human cancer". Cancer, 1987, 59, 10, 1692.

[6] Schmauz Z. R., Okong P., De Villiers E. M. et al.: "Multiple infections in cases of cervical cancer from a high incidence in tropical Africa". Int. J. Cancer, 1989, 43, 805.

[7] De Sanjose S., Munoz N., Bosch F. X. et al.: "Sexually transmitted agents and cervical neoplasia in Colombia and Spain". Int. J. Cancer, 1994, 56, 358.

[8] Zhang Z. F., Graham S., Yu S. Z. et al.: "Trichomonas vaginalis and cervical cancer. A prospective study in China". Ann. Epidemiol., 1995, 5, 325.

[9] Koutsky L. A. et al.: "A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection". N. Engl. J. Med., 1992, 327, 1272.

[10] Stone K. M., Zaidi A., Rosero-Bixby L. et al.: "Sexual behavior, sexually transmitted diseases and risk of cervical cancer". Epidemiology, 1995, 6, 409.

[11] Schlott T., Ruda G., Hopper! M. et al.: "The in situ polymerase chain reaction for detection of Chlamydia trachomatis". J. Histochem Cytochem, 1998, 46, 1017.

[12] Antilla T., S幻ku P., Koskela P. et al.: "Seotypes of Chlamydia Irachomatis and risk for development of cervical squamous cell carcinoma". JAMA, 2001, 285 (1), 47.

[13] Pfeiffer D., Stellwag B., Pfeiffer A. et al.: "Clinical implications of epidermal growth factor in the squamous cell carcinoma of the uterine of cervix". Gynecol. Oneal., 1989, 33, 146.

[14] Dellas A., Schultheiss E., Almendral A. C. et al.: "Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki 67 distribution in cervical intraepithelial neoplasms". Int. J. Cancer, 1996, 69, 165.

[15] Todaro G. J., Fryling C., De Larco J. E.: "Transforming growth factors produced by certain human tumor cells: polipeptydes that interact with epidermal growth factor receptors". PNAS 77, 1980, 5258.

[16] Y nos F. P., Klos D. J., Hamilton P. D. et al.: "Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions". Anticancer Res., 1992, 12, 1151.

[17] Konishi I., Ishikava Y., Wang S. Y. et al.: "Expression of transforming growth factor a in the normal cervix and in benign and malignant lesions of uterine cervix". Br. J. Obstet. Gynecol., 1994, 101, 325.

[18] Stoscheck C. M., King L. E.: "Role of epidermal growth factor in carcenogenesis". Cancer Res., 1986, 46, 1030.

[19] Carpenter G., Cohen S.: "Epidermal growth factor". Ann. Rev. Biochem., 1979, 48, 193.

[20] Goustin A. S., Leof E. B., Shipley G. D., Moses H. L.: "Growth factors and cancer". Cancer Res., 1986, 46, 1015.

[21] Heldin C. H., Westermark B.: "Growth factors: mechanism of action and relation to oncogenes". Cell., 1984, 37, 9.

[22] O'Keefe E., Hollenberg M. D., Cuatrcasas P.: "Epidermal growth factor characteristics of specific binding membranes from liver, placenta and other target tissue". Arch. Bioch. Biophys, 1974, 164, 518.

[23] Berchuck A., Rodriguez G., Kamel et al.: "Expression of epidermal growth factor receptor and HER-2/Neu in normal and neoplastic cervix, vulva and vagina". Obstet. Gynec., 1990, 76, 381.

[24] Kim J. W., Kim Y. T., Kim D. Y. et al.: "Expression of epidermal growth factor receptor in carcinoma of the cervix". Gynecol. Oncol., 1966, 60, 283.

[25] Bauknecht T., Kohler M., Janz I., Pfeiderer A.: "The occurence of epidermal growth factor receptors and the characterisation of EGF-like factors in human ovarian, endometrial, cervical and breast cancer". J. Cancer Res. Clin. Oncol., 1989, 115, 193.

[26] Al-Saleh W., Delvenne P., Greimers R. et al.: "Assessment of Ki 67 antigen imunostaining in squamous intraepithelial lesions of the uterine cervix". Anta. Pathology. 1995, 104, 154.

[27] Zur Hausen H.: "Papillomaviruses in human cancers". Proc. Assoc. Am. Phys., 1999, 111 (6), 581.

[28] Durst M., Gissmann L., Ilenberg H., Zur Hausen H.: "A papillomavirus DNA from cervical carcinomas and its prevalence in cancer biopsy samples from different geografic regions". Proc. Nat. Acad. SU, 1983, 80, 3812.

[29] Bosch F. X., Munoz N., Shah K. V., Mehens A.: "Second international workshop on the epidemiology of cervical cancer and human papillomavirus". Int J. Cancer, 1992, 52, 171.

[30] Tabrizi S. N., Fairley C. K., Chen S. et al.: "Epidemiological characteristics of women with high grade CIN who do and do not have human pap仆lomavirus". 1999, 101, 252.

[31] Ferrara A., Baay M. F. D., Herbrink P. et al.: "A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras". Int. J. Cancer, 1997, 73, 781.

[32] Hakama M., Lehtinen M., Knekt P. et al.: "Serum antibodies and subsequent cervical neoplasm: a prospective study with I 2 years of follow-up". Am. J. Epidemiol., 1993, 137, 166.

[33] Takac J., Gorisek B.: "The frequency of Chlamydia trachomatis infection in women with intraepithelial neoplasia of the uterine cervix". Eur. J. Gynaecol. Oncol., 1998, 19, (5), 492.

[34] Taka{;J., Gorisek B.: "Chlamydia trachomatis in women with and without cervical intraepithelial neoplasia". Int. J. STD. AIDS, 1999, 10 (5), 331.

[35] Woodworth C. D., Mcmullin E., Iglesias M., Plowman G. D.: "Interleukin I a and tumor necrosis factor a stimulate autocrine amphiregulin expression and proliferation of human papillomavims- immortalized and carcinoma-derived cervical epithelial cells". Proc. Nat. Acad. Sci., 1995, 92, 2840.

[36] Markowska J., Fischer N., Filas V. et al.: "The role of Chlamydia trachomatis infection in cervical cancer development". Eur. J. Oncol., 1998, 20, (2), 144.

[37] Lehmann M., Groh A., Rodel J. et al.: "Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus". J. Infect., 1999, 38 (I), 12.